STTK SEC Filings: 8-K, 10-Q, S-3 & 424B – Shattuck Labs

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 5, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 11, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 7, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Mar 5, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 6, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 14, 2025

News

TYPE

HEADLINE

FILED AT

8-K

Shattuck Labs Reports Third Quarter 2026 Financial Results and Provides Pipeline Updates

Nov 5, 2026

8-K

Shattuck Labs Reports Second Quarter 2026 Financial Results and Pipeline Progress

Aug 11, 2026

8-K

Shattuck Labs, Inc. Announces Pricing of Underwritten Public Offering

Jun 11, 2026

8-K

Shattuck Labs Announces Positive Phase 1 Results for SL-325 and Outlines Clinical Development Plans

Jun 9, 2026

8-K

Shattuck Labs, Inc. Announces Results of 2026 Annual Meeting of Stockholders

Jun 2, 2026

8-K

Shattuck Labs Reports First Quarter 2026 Financial Results and SL-325 Clinical Progress

May 7, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B5

REGISTERED OFFERING

Jun 11, 2026

424B5

PENDING FIXED PRICE OFFERING | Bank: Leerink Partners, J.P. Morgan, Piper Sandler, Cantor

Jun 9, 2026

424B5

January 2026 ATM | Offering amount: $75,000,000 | Bank: Leerink Partners LLC

Jan 22, 2026

424B3

UPDATED | SHARE RESALE REGISTRATION | Shares amount: 105,270,692 | Warrants amount: 52,025,834 | Warrants exercise price: $1.08

Sep 29, 2025

424B5

March 2025 ATM

Mar 27, 2025

424B3

UPDATED | SHARE RESALE REGISTRATION | Shares amount: 3,100,823 | Warrants amount: 3,100,823

Feb 2, 2024

Registrations

TYPE

HEADLINE

FILED AT

S-8

Shattuck Labs, Inc. Notice of Grant of Inducement Nonstatutory Stock Options

Aug 11, 2026

S-3

January 2026 SHELF

Jan 13, 2026

S-3

SHARE RESALE REGISTRATION

Sep 18, 2025

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Mar 27, 2025

S-8

Registration

Feb 29, 2024

S-3

SHARE RESALE REGISTRATION | Shares amount: 3,100,823 | Share price: $9.52 | Warrants amount: 3,100,823 EFFECTIVE

Jan 24, 2024

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 8, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 8, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

May 21, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

May 21, 2025

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 23, 2024

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 23, 2024

Ownerships

TYPE

HEADLINE

FILED AT

SCHEDULE 13G

BlackRock, Inc. (Filed by)

Oct 27, 2026

SCHEDULE 13G/A

T. Rowe Price Investment Management, Inc. (Filed by)

Aug 14, 2026

SCHEDULE 13D/A

Redmile Group, LLC (Filed by)

Jul 17, 2026

Shukla Abhinav A. (Reporting)

Jul 7, 2026

Shukla Abhinav A. (Reporting)

Jul 2, 2026

Pandite Arundathy N. (Reporting)

Jul 2, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Jan 22, 2026

CORRESP

Form CORRESP - Correspondence

Jan 16, 2026

LETTER

Form UPLOAD - SEC-generated letter

Jan 16, 2026

EFFECT

Form EFFECT - Notice of Effectiveness

Sep 29, 2025

CORRESP

Form CORRESP - Correspondence

Sep 24, 2025

LETTER

Form UPLOAD - SEC-generated letter

Sep 24, 2025

Shattuck Labs, Inc. STTK · SEC Filings